eNews May 17, 2022

The latest news affecting you and your customers… from the Independent Medical Specialty Dealers Association

Barbara Strain/Dee Donatelli

What you don’t know about materials management and evidence-based value analysis can impede your efforts to provide your customers and their patients of life-saving medical technologies. This July, the IMDA/HIRA Annual Conference will offer you a rare opportunity to learn from, question, challenge and inform two highly regarded experts on healthcare materials management and value analysis – Barbara Strain, MA, CVAHP, and Dee Donatelli, RN, CMRP, CVAHP. Barbara Strain is a founding member, past president and former region director of the Association of Healthcare Value Analysis Professionals (AHVAP) and is a member of the Association for Health Care Resource & Materials Management (AHRMM). Dee Donatelli is former president of AHVAP and served as chair of the board of directors of AHRMM. Register by May 31 for the IMDA/HIRA Annual Conference, “Winning Through Collaboration: Finding Opportunities Through Collaboration,” July 25-27 at the Eaglewood Resort in Itasca, Illinois, and take advantage of an advanced-registration discount.


Bell Medical acquires Bay State Anesthesia

Bell Medical, which purchased Bay State Anesthesia on April 1, plans to continue to use the Bay State Anesthesia name and to run the operation with all current sales and service staff with little change in the eye of the customer, according to Kevin Lueders, president. Bay State Anesthesia has been providing anesthesia and respiratory specialty products and services to the New England market since 1970. Bell Medical is a national distributor that has specialized in anesthesia sales and service since 1975.


Home use granted for respiratory monitoring device

Philadelphia-based Strados Labs, which develops smart sensor platforms to detect and predict conditions associated with serious, chronic respiratory diseases, received FDA Class II 510(k) clearance for home use of its first product, RESP®. This latest clearance enables patients to track objective symptoms associated with pulmonary disease at home and connect to a doctor remotely via telehealth and RPM. RESP technology has the ability to detect lung sounds associated with events like heart failure, COPD, asthma, and infectious diseases like COVID-19, according to the company. Clinicians will also now have the ability to track signals of improvement or decline in patients that might be experiencing these events.


Potential risk from silicone tubing

The FDA is evaluating the potential risk of exposure to non-dioxin-like (NDL) polychlorinated biphenyl acids (PCBAs) and NDL polychlorinated biphenyls (PCBs) with the following hemodialysis machines manufactured by Fresenius Medical Care: the 2008T, 2008K2, and 2008K models. The source of the NDL PCBAs and NDL PCBs is from the silicone tubing used as a part of the hydraulics in the machine and the dialysate lines. Although this silicone tubing does not directly contact the blood, there is the potential for back filtering through the dialyzer into the patient’s blood circulation during treatment, according to FDA.


COPD screening in asymptomatic adults

Screening for COPD in asymptomatic adults has no net benefit, per the US Preventive Services Task Force, affirming its 2016 recommendation. Although the USPSTF does not recommend routine screening for COPD in the general population using any method, screening questionnaires and spirometry without a bronchodilator have sometimes been used to identify persons at increased risk for COPD. If results are positive, such screening tests would require follow-up diagnostic testing. Chronic lower respiratory disease, composed mainly of COPD, is the sixth leading cause of death in the US.


Health system to collaborate on digital solutions

Intermountain Health will collaborate with investment firm General Catalyst to explore opportunities “to accelerate the shift to value-based care through digital and other solutions,” leaning heavily on General Catalyst’s Health Assurance Network companies, including Transcarent, Olive, Commure, Cadence and Sprinter Health. It is the third such collaboration General Catalyst has announced in the past 10 months, following agreements with HCA Healthcare and Jefferson Health.